Latest gross profit for CDNA: $160M, below the Healthcare sector average of $67B.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2026
Trailing 12 months ending Jun 30, 2026
Caredx (CDNA) currently reports a gross profit of $160M as of June 2026. That compares with $230M in the prior-year period — down 31.4% year over year. That is below the Healthcare sector average of $67B. Use the charts on this page to explore Caredx's gross profit history and peer comparisons.
Caredx's gross profit decreased from $230M to $160M — a 31.4% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Caredx's gross profit of $160M is lower than the Healthcare sector average of $67B. That is roughly 99.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
Caredx reported $160M in gross profit as of June 2026. That compares with $230M in the prior-year period — down 31.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current gross profit of $160M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $67B. From there, open related valuation or income-statement pages for Caredx, and consider following CDNA for alerts when major investors trade the stock.